Anaptysbio (ANAB) Receivables (2016 - 2026)
Anaptysbio's Receivables came in at $25.75 million for Q1 2026, up 44.0% from $17.88 million a year earlier but down 23.9% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Receivables (2016 - 2026) Analysis & Trends
At the end of FY2025, Anaptysbio's Receivables was $33.85 million, down 17.0% from FY2024.
- Receivables carries a four-year compound annual growth rate of 149.3% (FY2021 to FY2025).
- Going back by year, Receivables was $40.77 million in FY2024 (+495.0%), $6.85 million in FY2023 (+382.8%), $1.42 million in FY2022 (+62.0%) and $876,000 in FY2021.
- The five-year range for quarterly Receivables is $642,000 (Q2 2021) to $75.69 million (Q3 2025).
- Year-over-year, Receivables increased in seven of the last eight quarters, with growth averaging 223.6%.
- The fastest year-over-year change in Receivables over five years came in Q3 2025 (growth of 520.6%), and the weakest in Q1 2022 (a decline of 26.1%).
- Business Quant data shows ANAB's Receivables at $33.85 million (Q4 2025), $75.69 million (Q3 2025) and $21.42 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Anaptysbio | 1.47 Bn | 362.02 Mn | - | 25.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 25.75 Mn |
| Dec 31, 2025 | 33.85 Mn |
| Sep 30, 2025 | 75.69 Mn |
| Jun 30, 2025 | 21.42 Mn |
| Mar 31, 2025 | 17.88 Mn |
| Dec 31, 2024 | 40.77 Mn |
| Sep 30, 2024 | 12.20 Mn |
| Jun 30, 2024 | 9.01 Mn |
| Mar 31, 2024 | 7.09 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 3.18 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 921,000.00 |
| Dec 31, 2021 | 876,000.00 |
| Sep 30, 2021 | 761,000.00 |
| Jun 30, 2021 | 642,000.00 |
API Access
Anaptysbio Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();